- Home
- SMTI vs NCV Comparison
SMTI vs NCV Comparison
Compare SMTI & NCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- NCV
- Stock Information
- Founded
- SMTI 1982
- NCV 2003
- Country
- SMTI United States
- NCV United States
- Employees
- SMTI N/A
- NCV N/A
- Industry
- SMTI Medical/Dental Instruments
- NCV Finance Companies
- Sector
- SMTI Health Care
- NCV Finance
- Exchange
- SMTI Nasdaq
- NCV Nasdaq
- Market Cap
- SMTI 266.7M
- NCV 274.5M
- IPO Year
- SMTI N/A
- NCV N/A
- Fundamental
- Price
- SMTI $35.10
- NCV $13.44
- Analyst Decision
- SMTI Strong Buy
- NCV
- Analyst Count
- SMTI 2
- NCV 0
- Target Price
- SMTI $48.50
- NCV N/A
- AVG Volume (30 Days)
- SMTI 21.7K
- NCV 405.1K
- Earning Date
- SMTI 05-14-2025
- NCV 01-01-0001
- Dividend Yield
- SMTI N/A
- NCV 12.48%
- EPS Growth
- SMTI N/A
- NCV N/A
- EPS
- SMTI N/A
- NCV N/A
- Revenue
- SMTI $86,672,425.00
- NCV N/A
- Revenue This Year
- SMTI $23.68
- NCV N/A
- Revenue Next Year
- SMTI $5.80
- NCV N/A
- P/E Ratio
- SMTI N/A
- NCV N/A
- Revenue Growth
- SMTI 33.36
- NCV N/A
- 52 Week Low
- SMTI $25.86
- NCV $2.84
- 52 Week High
- SMTI $39.08
- NCV $3.59
- Technical
- Relative Strength Index (RSI)
- SMTI 67.89
- NCV 64.23
- Support Level
- SMTI $30.54
- NCV $12.93
- Resistance Level
- SMTI $32.78
- NCV $13.39
- Average True Range (ATR)
- SMTI 1.09
- NCV 0.18
- MACD
- SMTI 0.39
- NCV 0.07
- Stochastic Oscillator
- SMTI 91.18
- NCV 93.38
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About NCV Virtus Convertible & Income Fund of Beneficial Interest
Virtus Convertible & Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and high current income. It intends to achieve the objective by investing in a portfolio of domestic convertible securities and non-convertible income-producing securities. Its portfolio of investments includes Software, the Internet, the Commercial Services sector in the form of Convertible Bonds and Notes, and Media, Oil, Gas & Consumable Fuels, and Entertainment sector in the form of Corporate Bonds and Notes.